Javascript must be enabled to continue!
Evaluating the effect of methotrexate on the rate of renal fibrosis by elastography and fibrosis-related gene expression
View through CrossRef
Methotrexate is mainly used to treat diseases such as rheumatoid arthritis (RA), but its potential for nephrotoxicity has always been a significant concern on the use of this medication. This study aimed to determine the rate of renal fibrosis using transient elastography and its relationship with cumulative dose and duration of drug use in patients with rheumatoid arthritis treated with methotrexate. TGFβ gene expression was also assessed for further evaluation. Patients with rheumatoid arthritis who received methotrexate for more than six months were included. Renal fibrosis was determined by measuring the stiffness of the kidney by elastography (FiberScan Device). RA patients were divided into two groups based on kidney stiffness measurement with and without renal fibrosis, and demographic, clinical, and biochemical parameters were compared to investigate the relationship between cumulative dose and duration of methotrexate treatment and renal fibrosis. Also, in this study, 50 controls (healthy people) and 50 cases (RA patients) were used to evaluate the expression of the TGFβ gene by real-time PCR method. The existence of kidney fibrosis was observed in 10 patients. There was no significant relationship between renal fibrosis and the cumulative dose (P = 0.21) and duration of methotrexate (P = 0.30). Multivariate regression analysis showed that the chances of developing renal fibrosis in patients increase with increasing serum ALT levels (P = 0.01). The results of the TGFβ gene expression showed that the expression of this gene in the group of RA patients with fibrosis was higher than the control group (healthy people) and the group of RA patients without fibrosis (P <0.01). These results showed that evaluation of renal fibrosis by elastography method is recommended for scanning RA patients while they are being treated with methotrexate, which is also confirmed by the results of the fibrosis-related-gene expression.
Title: Evaluating the effect of methotrexate on the rate of renal fibrosis by elastography and fibrosis-related gene expression
Description:
Methotrexate is mainly used to treat diseases such as rheumatoid arthritis (RA), but its potential for nephrotoxicity has always been a significant concern on the use of this medication.
This study aimed to determine the rate of renal fibrosis using transient elastography and its relationship with cumulative dose and duration of drug use in patients with rheumatoid arthritis treated with methotrexate.
TGFβ gene expression was also assessed for further evaluation.
Patients with rheumatoid arthritis who received methotrexate for more than six months were included.
Renal fibrosis was determined by measuring the stiffness of the kidney by elastography (FiberScan Device).
RA patients were divided into two groups based on kidney stiffness measurement with and without renal fibrosis, and demographic, clinical, and biochemical parameters were compared to investigate the relationship between cumulative dose and duration of methotrexate treatment and renal fibrosis.
Also, in this study, 50 controls (healthy people) and 50 cases (RA patients) were used to evaluate the expression of the TGFβ gene by real-time PCR method.
The existence of kidney fibrosis was observed in 10 patients.
There was no significant relationship between renal fibrosis and the cumulative dose (P = 0.
21) and duration of methotrexate (P = 0.
30).
Multivariate regression analysis showed that the chances of developing renal fibrosis in patients increase with increasing serum ALT levels (P = 0.
01).
The results of the TGFβ gene expression showed that the expression of this gene in the group of RA patients with fibrosis was higher than the control group (healthy people) and the group of RA patients without fibrosis (P <0.
01).
These results showed that evaluation of renal fibrosis by elastography method is recommended for scanning RA patients while they are being treated with methotrexate, which is also confirmed by the results of the fibrosis-related-gene expression.
Related Results
Advancements in Elastography for Evaluating Fibrosis in Renal Transplants: Current Perspectives
Advancements in Elastography for Evaluating Fibrosis in Renal Transplants: Current Perspectives
Renal fibrosis is a leading cause of chronic allograft nephropathy. While renal biopsy remains the gold standard for diagnosing fibrosis, it is an invasive procedure with potential...
Comparison of Sodium Bicarbonate and Lactated Ringers Hydration for High-dose Methotrexate Chemotherapy in Children
Comparison of Sodium Bicarbonate and Lactated Ringers Hydration for High-dose Methotrexate Chemotherapy in Children
Background:
High-dose methotrexate is part of the treatment of pediatric cancers. To reduce the risk of toxicity, supportive measures, including hydration and alkaliniz...
From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease
From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease
Chronic liver disease is a late stage of progressive hepatic fibrosis. It consists of functional and structural disruptions in most chronic liver diseases. An accurate diagnosis al...
Expression and polymorphism of genes in gallstones
Expression and polymorphism of genes in gallstones
ABSTRACT
Through the method of clinical case control study, to explore the expression and genetic polymorphism of KLF14 gene (rs4731702 and rs972283) and SR-B1 gene (rs...
Comparison of laparoscopic tubal-preserving surgical management versus methotrexate therapy for tubal pregnancy: A conventional and network meta-analysis
Comparison of laparoscopic tubal-preserving surgical management versus methotrexate therapy for tubal pregnancy: A conventional and network meta-analysis
Background
Tubal pregnancy is one of the common emergencies in obstetrics and gynecology. There are various treatment options for tubal pregnancy. However, there is no consensus on...
Methotrexate Induced Lymphadenitis: A Case Report
Methotrexate Induced Lymphadenitis: A Case Report
INTRODUCTION: Methotrexate-induced lymphadenitis (MILA), a rare adverse effect of methotrexate treatment, occurs in a small percentage of patients using the drug for autoimmune dis...
Methotrexate Induced Lymphadenitis: A Case Report
Methotrexate Induced Lymphadenitis: A Case Report
INTRODUCTION: Methotrexate-induced lymphadenitis (MILA), a rare adverse effect of methotrexate treatment, occurs in a small percentage of patients using the drug for autoimmune dis...
Effects of antioxidant alfa-lipolic acid on polyphenol oxidase activity of acitretin- methotrexate combination in rat spleen tissue
Effects of antioxidant alfa-lipolic acid on polyphenol oxidase activity of acitretin- methotrexate combination in rat spleen tissue
Objectives: Acitretin, a lipophilic weak acid, is a slightly water-soluble vitamin A analog. Methotrexate is a folic acid analogue and an antimetabolite used for the treatment of m...

